Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants
Left ventricular thrombus (LVT) is a serious risk factor for systemic embolism development. Despite the evident danger of this condition, current guidelines describe management of patients with this potentially fatal complication very briefly. LVT can complicate myocardial infarction where its incid...
Saved in:
Main Authors: | A. D. Aga, A. A. Sokolova, D. A. Napalkov |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2023-01-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2862 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY
by: D. A. Napalkov, et al.
Published: (2015-09-01) -
Clinical outcomes of direct oral anticoagulant off-label dosing in nonvalvular atrial fibrillation
by: M. Jansson, et al.
Published: (2025-09-01) -
Pharmacogenetic substantiation of personalized prescription of oral anticoagulants in clinical practice
by: K.I. Bentsionova, et al.
Published: (2023-03-01) -
Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice
by: A. A. Zarudsky, et al.
Published: (2020-03-01) -
Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation
by: M. A. Gabitova, et al.
Published: (2020-01-01)